[1] |
SEIDMAN M D,GURGEL R K,LIN S Y,et al. Clinical practice guideline:allergic rhinitis[J]. Otolaryngol Head Neck Surg,2015,152(1 ):S1-43. DOI:10.1177/0194599814561600.
|
[2] |
YANG H J,KIM Y H,LEE B,et al. Unmet primary physicians' needs for allergic rhinitis care in Korea[J]. Allergy Asthma Immunol Res,2017,9(3):265-271. DOI:10.4168/aair.2017.9.3.265.
|
[3] |
MORTZ C G,LAURITSEN J M,BINDSLEV-JENSEN C,et al. Prevalence of atopic dermatitis,asthma,allergic rhinitis,and hand and contact dermatitis in adolescents. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis[J]. Br J Dermatol,2015,144(3):523-532. DOI:10.1046/j.1365-2133.2001.04078.x.
|
[4] |
中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 变应性鼻炎诊断和治疗指南(2015年,天津)[J]. 中华耳鼻咽喉头颈外科杂志,2016,51(1):6-24. DOI:10.3760/cma.j.issn.1673-0860.2016.01.004.
|
[5] |
隆莉芝,袁玲.患者报告结局的应用近况及思考[J].中国全科医学,2020,23(32):4120-4127. DOI:10.12114/j.issn.1007-9572.2020.00.015.
|
[6] |
薛红红,杨铮,万崇华,等.基于量表得分的最小临床重要性差值(MCID)制定方法[J].中国卫生统计,2019,36(3):436-440.
|
[7] |
路桃影,吴大嵘.最小重要差值及其在中医临床研究中的应用展望[J].中国中西医结合杂志,2013,33(4):544-548,558.
|
[8] |
JAESCHKE R,SINGER J,GUYATT G H. Measurement of health status. Ascertaining the minimal clinically important difference[J]. Control Clin Trials,1989,10(4):407-415. DOI:10.1016/0197-2456(89)90005-6.
|
[9] |
GUYATT G H,OSOBA D,WU A W,et al. Methods to explain the clinical significance of health status measures[J]. Mayo Clin Proc,2002,77(4):371-383. DOI:10.4065/77.4.371.
|
[10] |
杨丽虹,刘少南,吴大嵘,等.最小临床意义差值的概念及其估算方法[J].中国循证医学杂志,2020,20(11):1345-1352. DOI:10.7507/1672-2531.202007091.
|
[11] |
孙辉,谢洋,李建生.最小临床重要差值在COPD生存质量测评工具中的应用[J].中国全科医学,2015,18(23):2826-2829. DOI:10.3969/j.issn.1007-9572.2015.23.019.
|
[12] |
BARNES M L,VAIDYANATHAN S,WILLIAMSON P A,et al. The minimal clinically important difference in allergic rhinitis[J]. Clin Exp Allergy,2010,40(2):242-250. DOI:10.1111/j.1365-2222.2009.03381.x.
|
[13] |
DEVILLIER P,CHASSANY O,VICAUT E,et al. The minimally important difference in the Rhinoconjunctivitis Total Symptom Score in grass-pollen-induced allergic rhinoconjunctivitis[J]. Allergy,2015,69(12):1689-1695. DOI:10.1111/all.12518.
|
[14] |
VAN DER LEEUW S,VAN DER MOLEN T,RICHARD DEKHUIJZEN P N,et al. The minimal clinically important difference of the Control of Allergic Rhinitis and Asthma Test(CARAT):cross-cultural validation and relation with pollen counts[J]. NPJ Prim Care Respir Med,2015,25:14107.DOI:10.1038/npjpcrm.2014.107.
|
[15] |
EMONS J,FLOKSTRA B,JONG C D,et al. Use of the Control of Allergic Rhinitis and Asthma Test(CARATkids)in children and adolescents:validation in Dutch[J]. Pediatr Allergy Immunol,2017,28(2):185-190. DOI:10.1111/pai.12678.
|
[16] |
SCHATZ M,ZEIGER R S,CHEN W,et al. A comparison of the psychometric properties of the Mini-Rhinitis Quality of Life Questionnaire and the Rhinitis Control Assessment Test[J]. Am J RhinolAllergy,2012,26(2):127-133. DOI:10.2500/ajra.2012.26.3744.
|
[17] |
JUNIPER E F,THOMPSON A P,ROBERTS J N. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire[J]. J Allergy Clin Immunol,1999,104(2 Pt 1):364-369. DOI:10.1016/s0091-6749(99)70380-5.
|
[18] |
JUNIPER E F,THOMPSON A K,FERRIC P J,et al. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire[J]. Clin Exp Allergy,2000,30(1):132-140. DOI:10.1046/j.1365-2222.2000.00668.x.
|
[19] |
ROBERTS G,HURLEY C,LACK G. Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease[J]. J Allergy Clin Immunol,2003,111(3):491-497. DOI:10.1067/mai.2003.138.
|
[20] |
KIOTSERIDIS H,CILIO C M,BJERMER L,et al. Swedish translation and validation of the Pediatric Allergic Disease Quality of Life Questionnaire(PADQLQ)[J]. Acta Paediatr,2010,100(2):242-247. DOI:10.1111/j.1651-2227.2010.02028.x.
|
[21] |
BRAIDO F,BAIARDINI I,STAGI E,et al. RhinAsthma Patient Perspective:a short daily asthma and rhinitis QoL assessment[J]. Allergy,2012,67(11):1443-1450. DOI:10.1111/all.12014.
|
[22] |
DEMOLY P,AUBIER M,DEBLAY F,et al. Evaluation of patients' expectations and benefits in the treatment of allergic rhinitis with a new tool:the patient benefit index——the benefica study[J].Allergy Asthma Clin Immunol,2016,11(1):8. DOI:10.1186/s13223-015-0073-1.
|
[23] |
ABURUZ S M,BULATOVA N R,TAWALBEH M I. Development and validation of the Arabic allergic rhinitis quality of life questionnaire[J]. Saudi Med J,2009,30(12):1577-1583.DOI:10.1016/j.revmed.2009.09.015.
|
[24] |
HIGAKI T,OKANO M,KARIYA S,et al. Determining minimal clinically important differences in Japanese cedar/cypress pollinosis patients[J]. Allergol Int,2013,62(4):487-493. DOI:10.2332/allergolint.13-OA-0570.
|
[25] |
PFAAR O,DEMOLY P,VAN WIJK R G,et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergicrhinoconjunctivitis:an EAACI Position Paper[J]. Allergy,2014,69(7):854-867.DOI:10.1111/all.12383.
|
[26] |
FONSECA J A,NOGUEIRA S L,MORAIS-ALMEID M,et al. Validation of a questionnaire(CARAT10)to assess rhinitis and asthma in patients with asthma[J]. Allergy,2010,65(8):1042-1048. DOI:10.1111/j.1398-9995.2009.02310.x.
|
[27] |
LINHARES DV B R,DA FONSECA J A L,BORREGO L M,et al. Validation of Control of Allergic Rhinitis and Asthma Test for Children(CARATKids)——a prospective multicenter study[J]. Pediatr Allergy Immunol,2014,25(2):173-179. DOI:10.1111/pai.12218.
|
[28] |
SCHATZ M,MELTZER E O,NATHAN R,et al. Psychometric validation of the Rhinitis Control Assessment Test:a brief patient-completed instrument for evaluating rhinitis symptom control[J]. Ann Allergy Asthma Immunol,2010,104(2):118-124. DOI:10.1016/j.anai.2009.11.063.
|
[29] |
JUNIPER E F,GUYATT G H. Development and testing of a new measure of health status for clinical trials in rhinoeonjunctivitis[J]. Clin Exp Allergy,1991,21(1):77-83. DOI:10.1111/j.1365-2222.1991.tb00807.x.
|
[30] |
FRANZKE N,SCHÄFER I,JOST K,et al. A new instrument for the assessment of patient-defined benefit in the treatment of allergic rhinitis[J]. Allergy,2011,66(5):665-670. DOI:10.1111/j.1398-9995.2010.02515.x.
|
[31] |
OKUDA M,OHKUBO K,GOTO M,et al. Comparative study of two Japanese rhinoconjunctivitis quality-of-life questionnaires[J].Acta Otolaryngol,2005,25(7):736-744. DOI:10.1080/00016480510026944.
|
[32] |
ANGST F,AESCHLIMANN A,ANGST J. The minimal clinically important difference raised the significance of outcome effects above the statistical level,with methodological implications for future studies[J]. J Clin Epidemiol,2017,82:128-136. DOI:10.1016/j.jclinepi.2016.11.016.
|
[33] |
许清安,张传猛,万崇华,等.最小临床重要性差值MCID计算方法的计算机模拟研究[J].中国卫生统计,2017,34(5):785-787.
|
[34] |
JOHNSTON B C,EBRAHIM S,CARRASCO-LABRA A,et al. Minimally important difference estimates and methods:a protocol[J]. BMJ Open,2015,5(10):e007953. DOI:10.1136/bmjopen-2015-007953.
|